SG Americas Securities’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,064
| Closed | -$137K | – | 3145 |
|
|
2025
Q1 | $137K | Buy |
+30,064
| New | +$137K | ﹤0.01% | 2506 |
|
|
2024
Q4 | – | Sell |
-29,954
| Closed | -$145K | – | 3169 |
|
|
2024
Q3 | $145K | Buy |
+29,954
| New | +$145K | ﹤0.01% | 2466 |
|
|
2024
Q1 | – | Sell |
-50,802
| Closed | -$708K | – | 3022 |
|
|
2023
Q4 | $708K | Buy |
50,802
+32,087
| +171% | +$447K | 0.01% | 1125 |
|
|
2023
Q3 | $248K | Buy |
+18,715
| New | +$248K | ﹤0.01% | 1994 |
|
|
2023
Q1 | – | Sell |
-15,346
| Closed | -$297K | – | 3175 |
|
|
2022
Q4 | $297K | Buy |
15,346
+7,524
| +96% | +$146K | ﹤0.01% | 1729 |
|
|
2022
Q3 | $269K | Buy |
+7,822
| New | +$269K | ﹤0.01% | 1858 |
|
|
2021
Q4 | – | Sell |
-7,015
| Closed | -$330K | – | 3375 |
|
|
2021
Q3 | $330K | Buy |
+7,015
| New | +$330K | ﹤0.01% | 2623 |
|